These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34942515)

  • 21. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
    Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
    PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
    Yang Y; Wang S; Li T
    Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Guo H; Huang S; Li S; Yu H; Wu S; Zhou X
    Cancer Manag Res; 2018; 10():1763-1779. PubMed ID: 29988744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
    Serghiou S; Kyriakopoulou A; Ioannidis JP
    Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis.
    Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC
    Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
    Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
    Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of the prognostic value of long non-coding RNA PVT1 for cancer patients.
    Ma C; Nie XG; Wang YL; Wu DP; Liang QD
    Medicine (Baltimore); 2018 Dec; 97(49):e13548. PubMed ID: 30544468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
    Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
    Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).
    Ning L; Hu YC; Wang S; Lang JH
    Medicine (Baltimore); 2018 Aug; 97(32):e11481. PubMed ID: 30095613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic and prognostic significance of long noncoding RNAs expression in thyroid cancer: A systematic review and meta-analysis.
    Jing W; Li X; Peng R; Lv S; Zhang Y; Cao Z; Tu J; Ming L
    Pathol Res Pract; 2018 Mar; 214(3):327-334. PubMed ID: 29487006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.
    Sedlarikova L; Gromesova B; Kubaczkova V; Radova L; Filipova J; Jarkovsky J; Brozova L; Velichova R; Almasi M; Penka M; Bezdekova R; Stork M; Adam Z; Pour L; Krejci M; Kuglík P; Hajek R; Sevcikova S
    Eur J Haematol; 2017 Sep; 99(3):223-233. PubMed ID: 28543758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic lncRNA high expression for liver patients prognosis and medication guidance: a systematic review and meta-analysis.
    Zhu H; Chen H; Zhu X; Zhang B; Jin C
    Front Pharmacol; 2024; 15():1462512. PubMed ID: 39211780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pooled Analysis of The Clinical Utilities of Long Non-Coding RNA Based Molecular Signature for Diffuse Large B Cell Lymphoma.
    Xu P; Chen X; Su P
    Clin Lab; 2017 Nov; 63(11):1831-1840. PubMed ID: 29226652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.
    Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J
    Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
    Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
    BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of altered long noncoding RNAs in overall survival of ovarian cancer: A systematic review and meta-analysis.
    Seyed Hosseini E; Alizadeh Zarei M; Haddad Kashani H; Milajerdi A; Zare Dehghanani Z; Hassani Bafrani H; Nikzad H
    Pathol Res Pract; 2021 Mar; 219():153363. PubMed ID: 33621920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis.
    Cao F; Hu Y; Chen Z; Han W; Lu W; Xu J; Ding H; Shen X
    World J Surg Oncol; 2021 Mar; 19(1):89. PubMed ID: 33771184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.